Joovence Revenue and Competitors
Estimated Revenue & Valuation
- Joovence's estimated annual revenue is currently $425k per year.
- Joovence's estimated revenue per employee is $85,000
Employee Data
- Joovence has 5 Employees.
- Joovence grew their employee count by -37% last year.
Joovence's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Marketing Officer | Reveal Email/Phone |
Joovence Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $1.4M | 14 | -42% | N/A | N/A |
#2 | $22.4M | 132 | -7% | N/A | N/A |
#3 | $0.1M | 1 | -75% | N/A | N/A |
#4 | $0.3M | 4 | 0% | N/A | N/A |
#5 | $3.5M | 29 | -17% | N/A | N/A |
#6 | $9.2M | 60 | -14% | N/A | N/A |
#7 | $31.2M | 167 | -12% | N/A | N/A |
#8 | $4.1M | 30 | 3% | N/A | N/A |
#9 | $0.6M | 7 | -12% | N/A | N/A |
#10 | $4.8M | 35 | 13% | N/A | N/A |
What Is Joovence?
Joovence helps people get the smile they've always wanted at a price they can afford. Customers complete a single in-office checkup, and in a matter of weeks, Joovence sends them 3D printed custom clear aligners. In an average of just 6 months, our customers will straighten and whiten their teeth to perfection. Joovence is a healthcare company modernizing orthodontic treatment in France by reducing costs by up to 60% and minimizing the number of in-person appointments needed for treatment. We use proprietary technology and modern telehealth practices to diagnose, treat and monitor cases. Joovence's network of dental practitioners oversee the entire treatment process. Joovence is based in Paris and was founded in early 2018.
keywords:N/AN/A
Total Funding
5
Number of Employees
$425k
Revenue (est)
-37%
Employee Growth %
N/A
Valuation
N/A
Accelerator
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.4M | 5 | -44% | N/A |
#2 | $0.4M | 5 | -29% | N/A |
#3 | $0.4M | 5 | -44% | N/A |
#4 | $0.4M | 5 | -17% | N/A |
#5 | $0.4M | 5 | -29% | N/A |
